Pharmaceutical

Filter

Current filters:

None

Popular Filters

1 to 25 of 7000 results

Novo Nordisk buys production plant in New Hampshire

27-08-2014

Danish diabetes care giant Novo Nordisk (NOV: N) said today that it has acquired a manufacturing facility…

Mergers & AcquisitionsNovo NordiskOlympus BiotechPharmaceuticalProductionUSA

FDA backs added indication for GSK’s Promacta

FDA backs added indication for GSK’s Promacta

27-08-2014

The Food and Drug Administration has approved UK pharma giant GlaxoSmithKline’s supplemental New Drug…

GlaxoSmithKlineHematologyLigand PharmaceuticalsPharmaceuticalPromactaRare diseasesRegulationRevoladeUSA

Pfizer and Merck to explore potential of Xalkori/pembrolizumab combo

Pfizer and Merck to explore potential of Xalkori/pembrolizumab combo

26-08-2014

US pharma giants Pfizer and Merck & Co have inked an agreement to explore the therapeutic potential of…

Merck & CoOncologypembrolizumabPfizerPharmaceuticalResearchXalkori

Recipharm inks deal with Isofol Medical on Modufolin

Recipharm inks deal with Isofol Medical on Modufolin

26-08-2014

Swedish contract development and manufacturing group Recipharm and Isofol Medical AB, a Gothenburg-based…

FinancialIsofol MedicalModufolinOncologyPharmaceuticalProductionRecipharmResearch

Aspirin may reduce the risks of reoccurring blood clots

Aspirin may reduce the risks of reoccurring blood clots

26-08-2014

Aspirin may be a promising alternative for those who can’t take long-term anticoagulant drugs that…

AspirinCardio-vascularPharmaceuticalResearch

Vivus acquires topiramate patents from Janssen

Vivus acquires topiramate patents from Janssen

26-08-2014

USA-based pharma company Vivus has acquired a group of patents from Johnson & Johnson’s Janssen Pharmaceuticals…

AnorecticsEuropean Medicines AgencyJanssen PharmaceuticaLicensingObesityPharmaceuticalPhentermine/topiramateQsymiaTopiramateUSAVivus

China Biologic to up equity stake in Guizhou Taibang

China Biologic to up equity stake in Guizhou Taibang

26-08-2014

Plasma-based biopharma firm China Biologic Products says that its wholly-owned subsidiary Guiyang Dalin…

ChinaChina Biologic ProductsGuizhou Eakan PharmaceuticalGuizhou Taibang BiologicalMergers & AcquisitionsPharmaceutical

Roche makes another acquisition, paying $8.3 billion for InterMune

Roche makes another acquisition, paying $8.3 billion for InterMune

25-08-2014

Announcing its fourth acquisition this year, Swiss pharma major Roche said on Sunday that it has entered…

EsbrietInterMuneMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryRoche

ViiV Healthcare gains FDA approval for HIV drug Triumeq

ViiV Healthcare gains FDA approval for HIV drug Triumeq

23-08-2014

The US Food and Drug Administration has approved Triumeq (abacavir 600mg, dolutegravir 50mg and lamivudine…

Anti-viralsGlaxoSmithKlinePfizerPharmaceuticalRegulationShionogiTriumeqUSAViiV Healthcare

Hera Therapeutics’ HTI-1968 shuts down HPV that causes most cervical cancer

Hera Therapeutics’ HTI-1968 shuts down HPV that causes most cervical cancer

23-08-2014

Research presented at the 29th Annual International Papillomavirus Conference shows that a therapy being…

Anti-viralsHera Therapeuticshti-1968PharmaceuticalResearchWomen's Health

EXPERT VIEW: Pay-for-delay - GSK’s wait is almost over…

EXPERT VIEW: Pay-for-delay - GSK’s wait is almost over…

22-08-2014

If GlaxoSmithKline thought that the demise of the Office of Fair Trading (OFT) on April 1 would bring…

Activist UK LimitedGenericsGlaxoSmithKlineLicensingPatentsPharmaceuticalSeroxatUK

ADHD treatment market set to reach $9.9 billion by 2020

ADHD treatment market set to reach $9.9 billion by 2020

22-08-2014

The attention-deficit hyperactivity disorder (ADHD) therapeutics market value will rise from $6.9 billion…

ADHDEuropeJapanNeurologicalPharmaceuticalPsychiatryUSA

Insulin offers new hope for the treatment of acute pancreatitis

22-08-2014

Acute pancreatitis involves the pancreas digesting itself resulting in severe abdominal pain, vomiting…

DiabetesInflammatory diseasesPancreas disordersPharmaceuticalResearchUK

US DEA publishes final rule to reschedule hydrocodone combination products

US DEA publishes final rule to reschedule hydrocodone combination products

22-08-2014

The US Drug Enforcement Administration (DEA) has today published in the Federal Register the Final Rule…

AnalgesiaPharmaceuticalRegulationUS Drug Enforcement AdministrationUSA

1 to 25 of 7000 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top